This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miltner, E. C.
Right arrow Articles by Bermudez, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miltner, E. C.
Right arrow Articles by Bermudez, L. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2000, p. 1990-1994, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Mycobacterium avium Grown in Acanthamoeba castellanii Is Protected from the Effects of Antimicrobials

Elizabeth C. Miltner and Luiz E. Bermudez*

Kuzell Institute for Arthritis and Infectious Diseases, California Pacific Medical Center Research Institute, San Francisco, California

Received 4 October 1999/Returned for modification 26 March 2000/Accepted 24 April 2000

Mycobacterium avium is a common cause of systemic bacterial infection in patients with AIDS. Infection with M. avium has been linked to bacterial colonization of domestic water supplies and commonly occurs through the gastrointestinal tract. Acanthamoeba castellanii, a waterborne protozoan, may serve as an environmental host for M. avium. It has been shown that growth of M. avium in amoebae enhances invasion and intracellular replication of the bacteria in human macrophages and intestinal epithelial cell line HT-29 as well as in mice. We determined that growth of M. avium within A. castellanii influenced susceptibility to rifabutin, azithromycin, and clarithromycin. No significant activity against M. avium was seen with rifabutin, azithromycin, and clarithromycin when used to treat monolayers on both day 1 and day 4 after infection. When tested in a macrophage-like cell line (U937), all compounds showed significant anti-M. avium activity. Growth of M. avium in amoebae appears to reduce the effectiveness of the antimicrobials. These findings may have significant implications for prophylaxis of M. avium infection in AIDS.

* Corresponding author. Mailing address: Kuzell Institute, 2200 Webster St., Suite 305, San Francisco, CA 94115. Phone: (415) 561-1734. Fax: (415) 441-8548. E-mail: luizb{at}cooper.cpmc.org.

Antimicrobial Agents and Chemotherapy, July 2000, p. 1990-1994, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Eddyani, M., De Jonckheere, J. F., Durnez, L., Suykerbuyk, P., Leirs, H., Portaels, F. (2008). Occurrence of Free-Living Amoebae in Communities of Low and High Endemicity for Buruli Ulcer in Southern Benin. Appl. Environ. Microbiol. 74: 6547-6553 [Abstract] [Full Text]  
  • Adekambi, T., Ben Salah, S., Khlif, M., Raoult, D., Drancourt, M. (2006). Survival of Environmental Mycobacteria in Acanthamoeba polyphaga. Appl. Environ. Microbiol. 72: 5974-5981 [Abstract] [Full Text]  
  • Mura, M., Bull, T. J., Evans, H., Sidi-Boumedine, K., McMinn, L., Rhodes, G., Pickup, R., Hermon-Taylor, J. (2006). Replication and Long-Term Persistence of Bovine and Human Strains of Mycobacterium avium subsp. paratuberculosis within Acanthamoeba polyphaga. Appl. Environ. Microbiol. 72: 854-859 [Abstract] [Full Text]  
  • Sharbati-Tehrani, S., Stephan, J., Holland, G., Appel, B., Niederweis, M., Lewin, A. (2005). Porins limit the intracellular persistence of Mycobacterium smegmatis. Microbiology 151: 2403-2410 [Abstract] [Full Text]  
  • Brandl, M. T., Rosenthal, B. M., Haxo, A. F., Berk, S. G. (2005). Enhanced Survival of Salmonella enterica in Vesicles Released by a Soilborne Tetrahymena Species. Appl. Environ. Microbiol. 71: 1562-1569 [Abstract] [Full Text]  
  • Greub, G., Raoult, D. (2004). Microorganisms Resistant to Free-Living Amoebae. Clin. Microbiol. Rev. 17: 413-433 [Abstract] [Full Text]  
  • Primm, T. P., Lucero, C. A., Falkinham, J. O. III (2004). Health Impacts of Environmental Mycobacteria. Clin. Microbiol. Rev. 17: 98-106 [Abstract] [Full Text]  
  • Bermudez, L. E., Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., Young, L. S. (2003). Thiosemicarbazole (Thiacetazone-Like) Compound with Activity against Mycobacterium avium in Mice. Antimicrob. Agents Chemother. 47: 2685-2687 [Abstract] [Full Text]  
  • Taylor, S. J., Ahonen, L. J., de Leij, F. A. A. M., Dale, J. W. (2003). Infection of Acanthamoeba castellanii with Mycobacterium bovis and M. bovis BCG and Survival of M. bovis within the Amoebae. Appl. Environ. Microbiol. 69: 4316-4319 [Abstract] [Full Text]  
  • Marciano-Cabral, F., Cabral, G. (2003). Acanthamoeba spp. as Agents of Disease in Humans. Clin. Microbiol. Rev. 16: 273-307 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»